Discover opportunities months before the RFP drops
Learn more →Retrieving RFP details
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
The Drug Enforcement Administration (DEA) intends to award a sole source purchase order to Community Anti-Drug Coalitions of America (CADCA) for its participation in the 36th Annual National Leadership Forum. This federal Special Notice is not a grant and is pursued under sole source authority. The DEA's co-sponsorship includes workshops, conference registrations, exhibit space, and advertising.
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
The Drug Enforcement Administration (DEA) posted a Special Notice to pursue a sole-source purchase order with Community Anti-Drug Coalitions of America (CADCA) for DEA participation in the 36th Annual CADCA National Leadership Forum, scheduled February 2-5, 2026 at the National Harbor. The procurement requests a conference package (including three DEA-sponsored workshops, ten full conference registrations, exhibit hall space, and a full-page color advertisement) with contract performance from January 1 through April 30, 2026. The Special Notice was posted January 16, 2026 with a response deadline/closing date of February 2, 2026 at 2:00 PM.
Posted Date
Jan 16, 2026
Due Date
Feb 2, 2026
Release: Jan 16, 2026
Close: Feb 2, 2026
The Drug Enforcement Administration (DEA) posted a Special Notice to pursue a sole-source purchase order with Community Anti-Drug Coalitions of America (CADCA) for DEA participation in the 36th Annual CADCA National Leadership Forum, scheduled February 2-5, 2026 at the National Harbor. The procurement requests a conference package (including three DEA-sponsored workshops, ten full conference registrations, exhibit hall space, and a full-page color advertisement) with contract performance from January 1 through April 30, 2026. The Special Notice was posted January 16, 2026 with a response deadline/closing date of February 2, 2026 at 2:00 PM.
AvailableThe Air Education and Training Command (AETC) issued a Special Notice to sole-source a guest speaker (Eric Benken) for the First Sergeant Academy’s 'Courageous Leadership' module, requesting a two-hour instruction delivered across seven sessions annually with digital student materials. Period of performance begins Feb 23, 2026 with one base year and four option years through Feb 22, 2031, and place of performance is Maxwell AFB (Montgomery, AL) or an approved virtual platform. The notice is a procurement special notice for a sole-source contractor with a response deadline of Jan 29, 2026 and is listed as small business set-aside.
Posted Date
Jan 22, 2026
Due Date
Jan 29, 2026
Release: Jan 22, 2026
Close: Jan 29, 2026
The Air Education and Training Command (AETC) issued a Special Notice to sole-source a guest speaker (Eric Benken) for the First Sergeant Academy’s 'Courageous Leadership' module, requesting a two-hour instruction delivered across seven sessions annually with digital student materials. Period of performance begins Feb 23, 2026 with one base year and four option years through Feb 22, 2031, and place of performance is Maxwell AFB (Montgomery, AL) or an approved virtual platform. The notice is a procurement special notice for a sole-source contractor with a response deadline of Jan 29, 2026 and is listed as small business set-aside.
The National Cancer Institute issued a Special Notice (RFI-style informational notice) to gauge interest in staffing and managing an Occupational Health Services (OHS) Office at the Frederick National Laboratory for Cancer Research to support ~2,700 employees across laboratory and animal facilities. This notice is not a formal solicitation or grant; it requests information and preliminary questions with a response deadline of February 20, 2026, 3:00 PM ET and lists two public attachment documents (S26-114 OHS Support Request for Information.docx; SAM Special Notice_S26-114 OHS Support RFI.docx). The posting anticipates a one-year base with four option years, cites NAICS 621498, and identifies Leidos Biomedical Research, Inc. as the current FNLCR operator under the NCI prime contract.
Posted Date
Jan 9, 2026
Due Date
Feb 20, 2026
Release: Jan 9, 2026
Close: Feb 20, 2026
Construct sidewalk along 36th Street from Colonel Glenn Road to Boyle Park Road.
Posted Date
Jan 6, 2026
Due Date
Jan 27, 2026
Release: Jan 6, 2026
Close: Jan 27, 2026
Construct sidewalk along 36th Street from Colonel Glenn Road to Boyle Park Road.
AvailableSurface intent from meeting minutes, budgets, and contract expirations. Influence RFP requirements before competitors ever see them.
See your top 10 upcoming opportunities on a demo →Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
The National Cancer Institute issued a Special Notice (RFI-style informational notice) to gauge interest in staffing and managing an Occupational Health Services (OHS) Office at the Frederick National Laboratory for Cancer Research to support ~2,700 employees across laboratory and animal facilities. This notice is not a formal solicitation or grant; it requests information and preliminary questions with a response deadline of February 20, 2026, 3:00 PM ET and lists two public attachment documents (S26-114 OHS Support Request for Information.docx; SAM Special Notice_S26-114 OHS Support RFI.docx). The posting anticipates a one-year base with four option years, cites NAICS 621498, and identifies Leidos Biomedical Research, Inc. as the current FNLCR operator under the NCI prime contract.